| Synthesis and antihyperglycemic activity of chalcone based aryloxypropanolamines M Satyanarayana, P Tiwari, BK Tripathi, AK Srivastava, R Pratap Bioorganic & medicinal chemistry 12 (5), 883-889, 2004 | 341 | 2004 |
| Flavone-based novel antidiabetic and antidyslipidemic agents AK Verma, H Singh, M Satyanarayana, SP Srivastava, P Tiwari, AB Singh, ... Journal of medicinal chemistry 55 (10), 4551-4567, 2012 | 61 | 2012 |
| Ring-closing metathesis for the synthesis of a highly G-quadruplex selective macrocyclic hexaoxazole having enhanced cytotoxic potency M Satyanarayana, SG Rzuczek, EJ LaVoie, DS Pilch, A Liu, LF Liu, ... Bioorganic & medicinal chemistry letters 18 (13), 3802-3804, 2008 | 41 | 2008 |
| Macrocyclic hexaoxazoles: Influence of aminoalkyl substituents on RNA and DNA G-quadruplex stabilization and cytotoxicity M Satyanarayana, YA Kim, SG Rzuczek, DS Pilch, AA Liu, LF Liu, JE Rice, ... Bioorganic & medicinal chemistry letters 20 (10), 3150-3154, 2010 | 33 | 2010 |
| A review on HCV inhibitors: Significance of non-structural polyproteins NM Ganta, G Gedda, B Rathnakar, M Satyanarayana, B Yamajala, ... European journal of medicinal chemistry 164, 576-601, 2019 | 30 | 2019 |
| Synthesis and biological evaluation of (E)-N’-benzylidene-7-methyl-2-propyl-1H-benzo[d]imidazole-5-carbohydrazides as antioxidant, anti-inflammatory and analgesic agents R Katikireddy, R Kakkerla, MPSM Krishna, G Durgaiah, YN Reddy, ... Heterocyclic Communications 25 (1), 27-38, 2019 | 29 | 2019 |
| Syntheses and biological evaluation of topoisomerase I-targeting agents related to 11-[2-(N,N-dimethylamino)ethyl]-2,3-dimethoxy-8,9-methylenedioxy-11H-isoquino [4,3-c]cinnolin … M Satyanarayana, W Feng, L Cheng, AA Liu, YC Tsai, LF Liu, EJ LaVoie Bioorganic & medicinal chemistry 16 (16), 7824-7831, 2008 | 27 | 2008 |
| Chalcone-based aryloxypropanolamine as a potential antidiabetic and antidyslipidaemic agent P Shukla, M Satyanarayana, PC Verma, J Tiwari, AP Dwivedi, ... Current Science, 1675-1689, 2017 | 26 | 2017 |
| Novel topoisomerase I-targeting antitumor agents synthesized from the N,N,N-trimethylammonium derivative of ARC-111, 5H-2,3-dimethoxy-8,9-methylenedioxy-5-[(2-N,N,N … W Feng, M Satyanarayana, YC Tsai, AA Liu, LF Liu, EJ LaVoie European journal of medicinal chemistry 44 (9), 3433-3438, 2009 | 25 | 2009 |
| 12-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridines as novel topoisomerase I-targeting antitumor agents W Feng, M Satyanarayana, YC Tsai, AA Liu, LF Liu, EJ LaVoie Bioorganic & medicinal chemistry 17 (7), 2877-2885, 2009 | 23 | 2009 |
| Synthesis of N-substituted 5-[2-(N-alkylamino)ethyl]dibenzo[c,h][1,6]naphthyridines as novel topoisomerase I-targeting antitumor agents W Feng, M Satyanarayana, L Cheng, A Liu, YC Tsai, LF Liu, EJ LaVoie Bioorganic & medicinal chemistry 16 (20), 9295-9301, 2008 | 22 | 2008 |
| 11-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine derivatives as novel topoisomerase I-targeting agents W Feng, M Satyanarayana, YC Tsai, AA Liu, LF Liu, EJ LaVoie Bioorganic & medicinal chemistry 16 (18), 8598-8606, 2008 | 21 | 2008 |
| Facile formation of hydrophilic derivatives of 5H-8,9-dimethoxy-5-[2-(N,N-dimethylamino)ethyl]-2,3-methylenedioxydibenzo[c,h][1,6]naphthyridin-6-one (ARC-111) and its 12-aza … W Feng, M Satyanarayana, Y Tsai, AA Liu, LF Liu, EJ LaVoie Bioorganic & medicinal chemistry letters 18 (12), 3570-3572, 2008 | 16 | 2008 |
| Oxy Substituted chalcones as antihyperglycemic and antidyslipidemic agents R Pratap, M Satyanarayana, C Nath, R Raghubir, A Puri, R Chander, ... US Patent 7,807,712, 2010 | 10 | 2010 |
| Design, synthesis, and evaluation of novel combretastatin a‐4 based chalcone derivatives as anticancer agents B Rathnakar, GS Kumar, SP Mahammad, S Gattu, S Kalyani, R Nimma, ... Journal of Heterocyclic Chemistry 58 (2), 488-501, 2021 | 9 | 2021 |
| Acyclic pyrazolo[3,4-d]pyrimidine nucleoside as potential leishmaniostatic agent A Hasan, M Satyanarayana, A Mishra, DS Bhakuni, R Pratap, A Dube, ... Nucleosides, Nucleotides, and Nucleic Acids 25 (1), 55-60, 2006 | 9 | 2006 |
| Design, synthesis and evaluation of hybrid 2-heteroaryl benzimidazole-chalcone derivatives as anticancer agents GS Kumar, B Rathnakar, S Gattu, SS Jadav, N Rameshwar, S Boyapati, ... Letters in Organic Chemistry 18 (10), 766-776, 2021 | 7 | 2021 |
| Synthesis, DFT computations, molecular docking studies and anticancer activity of 2-(4-fluorophenyl)-3-(5-methylisoxazol-3-yl)thiazolidin-4-one G Ramesh, B Rathnakar, C Narsaiah, N Rameshwar, M Srinivas, ... Chemical Data Collections 39, 100859, 2022 | 5 | 2022 |
| Assay method for quality control and stability studies of a new anti-diabetic and anti-dyslipidemic flavone (S002-853) A Naqvi, A Pandey, V Gupta, R Malasoni, A Srivastava, RR Pandey, ... Pharmacognosy Magazine 11 (Suppl 1), S53, 2015 | 5 | 2015 |
| Development of molybdenum oxide promoted CeO2− SiO2 mixed‐oxide catalyst for efficient catalytic oxidation of benzylamine to N‐benzylidenebenzylamine M Ravula, V Dosarapu, S Bandalla, S Mavurapu, M Varkolu, A Rajeevan, ... ChemistrySelect 9 (10), e202304534, 2024 | 3 | 2024 |
Ed LaVoieProfessorVerified email at pharmacy.rutgers.edu
